Ipilimumab
| Ipilimumab | |
|---|---|
| Term | Ipilimumab |
| Short definition | ipilimumab (ih-pih-LIH-myoo-mab) A drug that binds to the protein CTLA-4 to help immune cells kill cancer cells better, and is used to treat many different types types of cancer is used. These include cancers that have certain mutations (changes) in genes involved in DNA repair. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
ipilimumab - (pronounced) (ih-pih-LIH-myoo-mab) A drug that binds to the protein CTLA-4 to help immune cells kill cancer cells better, and is used to treat many different types types of cancer is used. These include cancers that have certain mutations (changes) in genes involved in DNA repair. Ipilimumab is used alone or with other medicines to treat certain types of colon cancer, esophageal cancer, hepatocellular carcinoma (a type of liver cancer), malignant pleural mesothelioma, melanoma, non-small cell lung cancer, and renal cell carcinoma (a type of kidney cancer). It is also being studied in the treatment of other types of cancer. Ipilimumab can block CTLA-4 and help the immune system kill cancer cells. It's a type of monoclonal antibody and a type of immune checkpoint inhibitor. Also called MDX-010 and Yervoy
External links
- Medical encyclopedia article on Ipilimumab
- Wikipedia's article - Ipilimumab
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski